Aetna Policy Update Expands TMS Availability for Adolescents With Depression
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, […]
Exela Technologies and AIDEO Technologies Enter Strategic Alliance
IRVING, Texas, July 22, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA, XELAP), a leader in business […]
Connexa Regains Full Nasdaq Compliance
Connexa Receives Nasdaq Confirmation Bid Price Hearing Panel Cancelation, and Delisting Determination Withdrawn. Following June 27, 2024 Reverse Split and […]
CSW Industrials Announces Date for Fiscal First Quarter 2025 Earnings Release Conference Call
DALLAS, July 22, 2024 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (NASDAQ: CSWI) announced that it will release its earnings results […]
Open Lending to Announce Second Quarter 2024 Results on August 8, 2024
AUSTIN, Texas, July 22, 2024 (GLOBE NEWSWIRE) — Open Lending Corporation (NASDAQ: LPRO) (“Open Lending” or “the Company”), an industry […]
HeartCore to Authorize Second Dividend Payment
NEW YORK and TOKYO, July 22, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial Officer […]
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering
SAN JOSE, Calif., July 22, 2024 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a […]
Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the […]
NANO Nuclear Energy Appoints Distinguished Nuclear Regulatory Expert David Tiktinsky as Head of Nuclear Regulatory Licensing after nearly 40-years with the Nuclear Regulatory Commission (NRC)
Tiktinsky’s nearly 40 years of experience at the U.S. Nuclear Regulatory Commission to greatly assist NANO Nuclear in navigating the […]
